Ginkgo Bioworks
$0.37
24H
Market Cap
Volume
Supply
Price Chart
About Ginkgo Bioworks - DNA
Ginkgo Bioworks Holdings, Inc. is a biotechnology company known for its platform specializing in using genetic engineering to produce bacteria with industrial applications, including the manufacture of chemicals, materials, and pharmaceuticals through a process known as synthetic biology. They provide organism design and development services, leveraging their technology to program cells for a variety of markets.
What are Ginkgo Bioworks's core values and mission statement?
Ginkgo Bioworks Holdings, Inc. aims to make biology easier to engineer, enabling new products across a range of industries from pharmaceuticals to agriculture to fabrics. Core values revolve around fostering innovation, collaboration, and sustainability through the use of synthetic biology.
Who founded Ginkgo Bioworks and when?
Ginkgo Bioworks Holdings, Inc. was founded in 2009 by a team that includes Tom Knight, Jason Kelly, Reshma Shetty, Barry Canton, and Austin Che.
Who leads Ginkgo Bioworks?
Ginkgo Bioworks Holdings, Inc. is led by CEO Jason Kelly, one of the company's co-founders.
Where is Ginkgo Bioworks located, and what is its base country?
Ginkgo Bioworks Holdings, Inc. is headquartered in Boston, Massachusetts, United States.
On which exchanges is Ginkgo Bioworks traded?
Ginkgo Bioworks Holdings, Inc. is traded on the New York Stock Exchange (NYSE) under the ticker symbol "DNA."
Historical data
Ginkgo Bioworks (DNA) Price Live Data
The live price of Ginkgo Bioworks (DNA) is $0.37, with a trading volume of 41,710,936 in the last 24 hours. Wrapstocks updates the DNA price in real-time. Ginkgo Bioworks is up 8.63% in the last 24 hours. The company has a live market cap of $815,594,432.00 and a supply of 2,228,400,087 DNA stocks.
Ginkgo Bioworks (DNA) is traded on New York Stock Exchange, and currently, the market is closed; trading will be resumed in 8 hours and 27 minutes.
